PURA - Puration Targets Acquisition in $6.9 Billion CBD Gummies Market

Dallas, TX -- February 6, 2020 -- InvestorsHub NewsWire -- Puration, Inc. (OTC Pink: PURA) management today indicated plans to make a formal offer next week to acquire a CBD Infused Confections operation currently producing CBD Infused Gummies and CBD Infused Gum. The CBD Infused Gummies market alone is anticipated to reach $6.9 Billion by 2025. PURA recently announced plans to pursue the acquisition of operations producing cannabis infused beverages, edibles and topicals. PURA management anticipates securing a $5 million investment to fund acquisitions based on a recent term sheet. The proposed investment terms outline an up to $5 million debt facility whereby funds would be drawn as needed to fund acquisitions. The drawn funds would be secured by the acquired asset and the debt could be repaid in stock at $0.10 per share. PURA management anticipates closing on the $5 million investment soon with an announcement as early as Monday next week. The formal acquisition of the CBD Infused Confections operation is anticipated to follow promptly thereafter.

For more information on Puration, visit http://www.purationinc.com.

Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Contact:
Puration, Inc.
Brian Shibley
[e-mail]
[phone]